$599
Dual/triple agonist, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics

Abbott Dual CGKM CE Mark; Kailera Q1 ’26 Earnings; MiniMed Go Smart MDI US Launch; Insulet Omnipod Medical Device Correction

A series of cardiometabolic-related news items has been observed from Abbott, Kailera Therapeutics, MiniMed, and Insulet. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here
OR
Return to Home